Evotec (NASDAQ:EVO) Shares Gap Up - Still a Buy?

Evotec SE (NASDAQ:EVO - Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $3.58, but opened at $3.77. Evotec shares last traded at $3.85, with a volume of 32,036 shares traded.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft raised shares of Evotec from a "sell" rating to a "hold" rating in a research note on Thursday.

Evotec Trading Up 0.2 %

The company has a current ratio of 2.09, a quick ratio of 1.99 and a debt-to-equity ratio of 0.43. The stock's fifty day moving average price is $3.64 and its 200-day moving average price is $4.09.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. BNP Paribas Financial Markets purchased a new position in Evotec during the fourth quarter valued at approximately $27,000. CSS LLC IL acquired a new position in shares of Evotec in the fourth quarter worth $50,000. Bank of America Corp DE raised its holdings in shares of Evotec by 262.5% during the fourth quarter. Bank of America Corp DE now owns 12,828 shares of the company's stock worth $53,000 after acquiring an additional 9,289 shares in the last quarter. Lighthouse Investment Partners LLC acquired a new stake in Evotec during the fourth quarter valued at $166,000. Finally, DCF Advisers LLC increased its position in Evotec by 5.9% in the 4th quarter. DCF Advisers LLC now owns 229,871 shares of the company's stock worth $956,000 after purchasing an additional 12,816 shares during the last quarter. 5.81% of the stock is owned by institutional investors and hedge funds.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.